| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.04 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.04 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.04 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.04 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.061 | 0.04 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.04 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |